{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:54:04Z","timestamp":1780052044195,"version":"3.53.1"},"reference-count":15,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Roche Molecular Systems, Pleasanton, California"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2016,6,15]]},"abstract":"<jats:p>A <jats:italic>post hoc<\/jats:italic> analysis of the ATHENA study was performed to determine whether true HPV\u2010negative cervical lesions occur and whether they have clinical relevance. The ATHENA database was searched for all CIN2 or worse (CIN2+) cases with cobas HPV\u2010negative results and comparison was made with Linear Array (LA) and Amplicor to detect true false\u2010negative HPV results. Immunostaining with p16 was performed on these cases to identify false\u2010positive histology results. H&amp;E slides were re\u2010reviewed by the study pathologists with knowledge of patient age, HPV test results and p16 immunostaining. Those with positive p16 immunostaining and\/or a positive histopathology review underwent whole tissue section HPV PCR by the SPF10\/LiPA\/RHA system. Among 46,887 eligible women, 497 cases of CIN2+ were detected, 55 of which tested negative by the cobas<jats:sup>\u00ae<\/jats:sup> HPV Test (32 CIN2, 23 CIN3\/ACIS). By LA and\/or Amplicor, 32 CIN2+ (20 CIN2, 12 CIN3\/ACIS) were HPV positive and categorized as false\u2010negatives by cobas HPV; nine of 12 false\u2010negative CIN3\/ACIS cases were p16+. There were 23 cases (12 CIN2, 11 CIN3\/ACIS) negative by all HPV tests; seven of 11 CIN3\/ACIS cases were p16+. H&amp;E slides were available for six cases for re\u2010review and all were confirmed as CIN3\/ACIS. Tissue PCR was performed on the six confirmed CIN3\/ACIS cases (and one without confirmation): four were positive for HPV types not considered oncogenic, two were positive for oncogenic genotypes and one was indeterminate. In summary, subanalysis of a large cervical cancer screening study did not identify any true CIN3\/ACIS not attributable to HPV.<\/jats:p>","DOI":"10.1002\/ijc.30032","type":"journal-article","created":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T10:47:20Z","timestamp":1454755640000},"page":"2932-2939","source":"Crossref","is-referenced-by-count":52,"title":["Evaluating HPV\u2010negative CIN2+ in the ATHENA trial"],"prefix":"10.1002","volume":"138","author":[{"given":"Karl Ulrich","family":"Petry","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology Klinikum Wolfsburg Wolfsburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Thomas","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Health Services University of California Santa Barbara CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Johnson","sequence":"additional","affiliation":[{"name":"Roche Molecular Systems Pleasanton CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Quint","sequence":"additional","affiliation":[{"name":"DDL Diagnostic Laboratory Rijswijk The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruediger","family":"Ridder","sequence":"additional","affiliation":[{"name":"Ventana Medical Systems, Inc Tucson AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Thomas C.","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology Columbia University New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Behrens","sequence":"additional","affiliation":[{"name":"Roche Molecular Systems Pleasanton CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F"},{"key":"e_1_2_7_3_1","first-page":"45","article-title":"Primary cervical cancer truly negative for high\u2010risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents","volume":"30","author":"Liebrich C","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.439"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29651"},{"key":"e_1_2_7_6_1","volume-title":"WHO classification of tumors of female reproductive organs","author":"Kurman RJ","year":"2014"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.095"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPZ5JY6FCVNMOT"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.07.024"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e31826916c7"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.3970"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2013.09.015"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4405"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4424"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20244"},{"key":"e_1_2_7_16_1","first-page":"255","volume-title":"IARC monographs on the evaluation of carcinogenic risks to humans. Biological agents: a review of human carcinogens, vol. 100 B","author":"Human papillomaviruses. In:","year":"2012"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.30032","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.30032","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ijc.30032","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.30032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T12:47:09Z","timestamp":1696510029000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.30032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,6,15]]}},"alternative-id":["10.1002\/ijc.30032"],"URL":"https:\/\/doi.org\/10.1002\/ijc.30032","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]}}}